FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281829898> ?p ?o ?g. }

• W4281829898 endingPage "e052294" @default.
• W4281829898 startingPage "e052294" @default.
• W4281829898 abstract "Response Evaluation Criteria in Solid Tumours version 1.1 (RECIST 1.1) and modified RECIST (mRECIST) are commonly used to assess tumour response. Which one is better to evaluate efficacy after molecular targeted therapies in hepatocellular carcinoma (HCC) patients is still controversial. A systemic review was performed to compare the objective response rate (ORR) and disease control rate (DCR) and a meta-analysis was conducted to compare the correlation between objective response and overall survival (OS).Systematic review and meta-analysis using the Grading of Recommendations Assessment, Development and Evaluation approach.EMBASE, PubMed, Web of Science and Cochrane Library were searched through 31 December 2021.We included studies assessing the efficacy of molecular targeted therapy for HCC according to both RECIST 1.1 and mRECIST.Two investigators extracted data independently. The consistency between RECIST 1.1 vs mRECIST is measured by the k coefficient. HRs with corresponding 95% CIs were used for meta-analysis.23 studies comprising 2574 patients were included in systematic review. The ORR according to mRECIST is higher than RECIST1.1 (15.9% vs 7.8%, p<0.001). The DCR is similar (68.4% vs 67.2%, p=0.5). The agreement of tumour response is moderate for objective response (k=0.499) and perfect for progressive disease (k=0.901), calculated from 8 studies including 372 patients. OS was significantly longer in response group than non-response group according to mRECIST (HR 0.56, 95% CI 0.41 to 0.78, p=0.0004) calculated from 7 studies including 566 patients, however, the RECIST1.1 could not distinguish the OS well (HR 0.68, 95% CI 0.44 to 1.05, p=0.08). Subgroup analusis by type of treatment was conducted.mRECIST may be more accurate than RECIST 1.1 in assessing ORR after molecular targeted therapies in HCC patients and can better assess the prognosis. However, the performance of both criteria in assessing disease progression is identical.CRD42020200895.Ethics approval is not required in this meta-analysis." @default.
• W4281829898 created "2022-06-13" @default.
• W4281829898 creator A5005611137 @default.
• W4281829898 creator A5038397694 @default.
• W4281829898 creator A5043117784 @default.
• W4281829898 creator A5049501617 @default.
• W4281829898 creator A5058830819 @default.
• W4281829898 creator A5066385320 @default.
• W4281829898 date "2022-06-01" @default.
• W4281829898 modified "2023-10-15" @default.
• W4281829898 title "RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis" @default.
• W4281829898 cites W1521559493 @default.
• W4281829898 cites W1584669207 @default.
• W4281829898 cites W1739036892 @default.
• W4281829898 cites W1873011119 @default.
• W4281829898 cites W1906717577 @default.
• W4281829898 cites W1971837077 @default.
• W4281829898 cites W1989673992 @default.
• W4281829898 cites W2013953113 @default.
• W4281829898 cites W2017687774 @default.
• W4281829898 cites W2019607817 @default.
• W4281829898 cites W2024029636 @default.
• W4281829898 cites W2024340610 @default.
• W4281829898 cites W2051862748 @default.
• W4281829898 cites W2056227962 @default.
• W4281829898 cites W2079586464 @default.
• W4281829898 cites W2093592912 @default.
• W4281829898 cites W2104806470 @default.
• W4281829898 cites W2114018732 @default.
• W4281829898 cites W2116475791 @default.
• W4281829898 cites W2121713010 @default.
• W4281829898 cites W2141444851 @default.
• W4281829898 cites W2142020092 @default.
• W4281829898 cites W2160621323 @default.
• W4281829898 cites W2167805334 @default.
• W4281829898 cites W2277004004 @default.
• W4281829898 cites W2518265052 @default.
• W4281829898 cites W2528882804 @default.
• W4281829898 cites W2733307304 @default.
• W4281829898 cites W2786722961 @default.
• W4281829898 cites W2793539832 @default.
• W4281829898 cites W2796067155 @default.
• W4281829898 cites W2797552467 @default.
• W4281829898 cites W2883204623 @default.
• W4281829898 cites W2889646458 @default.
• W4281829898 cites W2965589433 @default.
• W4281829898 cites W2966212198 @default.
• W4281829898 cites W3000401463 @default.
• W4281829898 cites W3004690490 @default.
• W4281829898 cites W3015053767 @default.
• W4281829898 cites W3021228866 @default.
• W4281829898 cites W3092575360 @default.
• W4281829898 cites W3104543659 @default.
• W4281829898 cites W3137254944 @default.
• W4281829898 cites W3176209044 @default.
• W4281829898 cites W4200536069 @default.
• W4281829898 cites W2427033654 @default.
• W4281829898 doi "https://doi.org/10.1136/bmjopen-2021-052294" @default.
• W4281829898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35649603" @default.
• W4281829898 hasPublicationYear "2022" @default.
• W4281829898 type Work @default.
• W4281829898 citedByCount "4" @default.
• W4281829898 countsByYear W42818298982023 @default.
• W4281829898 crossrefType "journal-article" @default.
• W4281829898 hasAuthorship W4281829898A5005611137 @default.
• W4281829898 hasAuthorship W4281829898A5038397694 @default.
• W4281829898 hasAuthorship W4281829898A5043117784 @default.
• W4281829898 hasAuthorship W4281829898A5049501617 @default.
• W4281829898 hasAuthorship W4281829898A5058830819 @default.
• W4281829898 hasAuthorship W4281829898A5066385320 @default.
• W4281829898 hasBestOaLocation W42818298981 @default.
• W4281829898 hasConcept C126322002 @default.
• W4281829898 hasConcept C143998085 @default.
• W4281829898 hasConcept C2776478404 @default.
• W4281829898 hasConcept C2778019345 @default.
• W4281829898 hasConcept C2778822529 @default.
• W4281829898 hasConcept C2779134260 @default.
• W4281829898 hasConcept C2779984678 @default.
• W4281829898 hasConcept C71924100 @default.
• W4281829898 hasConcept C95190672 @default.
• W4281829898 hasConceptScore W4281829898C126322002 @default.
• W4281829898 hasConceptScore W4281829898C143998085 @default.
• W4281829898 hasConceptScore W4281829898C2776478404 @default.
• W4281829898 hasConceptScore W4281829898C2778019345 @default.
• W4281829898 hasConceptScore W4281829898C2778822529 @default.
• W4281829898 hasConceptScore W4281829898C2779134260 @default.
• W4281829898 hasConceptScore W4281829898C2779984678 @default.
• W4281829898 hasConceptScore W4281829898C71924100 @default.
• W4281829898 hasConceptScore W4281829898C95190672 @default.
• W4281829898 hasFunder F4320321001 @default.
• W4281829898 hasIssue "6" @default.
• W4281829898 hasLocation W42818298981 @default.
• W4281829898 hasLocation W42818298982 @default.
• W4281829898 hasLocation W42818298983 @default.
• W4281829898 hasOpenAccess W4281829898 @default.
• W4281829898 hasPrimaryLocation W42818298981 @default.
• W4281829898 hasRelatedWork W1584669207 @default.
• W4281829898 hasRelatedWork W2024340610 @default.

• next